• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • COVID-19

    Coronavirus: Gates gives $100 million to prevent virus spread

    The Gates Foundation increased its commitment to containing 2019-nCoV to up to $100 million on Wednesday, for detection, isolation, and treatment efforts, as well as to accelerate the development of vaccines, drugs, and diagnostics.

    By Sara Jerving // 05 February 2020
    Medical staff at work inside a coronavirus isolation ward at a government hospital in Chennai, India. Photo by: Reuters / P. Ravikumar

    NAIROBI — The Bill & Melinda Gates Foundation announced an increase in its commitment to containing 2019 novel coronavirus to up to $100 million on Wednesday. The funds will go toward improving detection, isolation, and treatment efforts, as well as accelerating the development of vaccines, drugs, and diagnostics. Funds will also be allocated for protecting countries in Africa and South Asia against the spread of the virus.

    More on the coronavirus

    ► Coronavirus: WHO sets the record straight on facts and misinformation

    ► Declaring coronavirus emergency alone is not enough, experts say

    ► Lab-grown novel coronavirus to speed up detection and response

    This news comes as health officials have confirmed over 20,630 cases of the new virus globally, with over 420 deaths. The outbreak has overwhelmed health systems in China, which hosts the vast majority of the cases. Last week, the World Health Organization declared the outbreak a global health emergency.

    “Multilateral organizations, national governments, the private sector and philanthropies must work together to slow the pace of the outbreak, help countries protect their most vulnerable citizens and accelerate the development of the tools to bring this epidemic under control,” said Gates Foundation CEO Mark Suzman in a press release.

    On Jan. 26, the foundation had committed $10 million in funds — half of which was allocated to the response in China and the other to preparedness measures in Africa. The $100 million commitment is inclusive of these initial funds.

    Since the foundation’s $10 million announcement — just over a week ago —  the number of cases has increased by over 18,600 cases globally.

    The Chinese government is scrambling to keep up with this exponentially increasing case count. A new 1,000-bed hospital was built in Wuhan — the virus’ epicenter — in a matter of days and began taking patients on Tuesday. Another new hospital with 1,600 beds will start to admit patients on Thursday.  

    Of the Gates Foundation’s funds, up to $20 million will go toward efforts to detect, isolate, and treat people with the virus. It will direct funds toward WHO, the U.S. Centers for Disease Control and Prevention, and national public health authorities in countries impacted — such as the National Health Commission of China and the Chinese Center for Disease Control and Prevention. The funding is aimed at helping to cover the initial costs of labor supplies.

    The rest of the world is also bracing for a potential spread — particularly regions that are underresourced and where health systems are already weak, such as Africa and South Asia.

    WHO is emphasizing the need for early detection in these countries, which includes surveillance at airports, such as fever screening.

    In a press briefing Tuesday, WHO said there are no confirmed cases of 2019-nCoV in Africa, but that the likelihood of cases of the virus spreading to the continent is “very, very high.”

    “We know how fragile the health system in the African continent [is] and these systems are already overwhelmed by many ongoing disease outbreaks, so for us it is critical to detect earlier so that we can prevent the spread within communities which can trigger quite a number of cases and easily overwhelm the treatment capacity,” said Dr. Michel Yao, emergency operations program manager at WHO's Africa Office, during a press briefing Tuesday.

    WHO has identified 13 top priority countries in Africa that are vulnerable to the spread of 2019-nCoV, because of high volumes of travel between those countries and China. Those include Algeria, Angola, Côte d’Ivoire, the Democratic Republic of the Congo, Ethiopia, Ghana, Kenya, Mauritius, Nigeria, South Africa, Tanzania, Uganda, and Zambia. It expects to have staff in these countries by the end of the week and is working to build up the diagnostic laboratory capacity across the continent.

    But other countries are concerned about whether they will have adequate support to fund their efforts to prepare.

    “We are extremely short on money,” said Dr. Akram Ali Altoum, federal minister of health in Sudan at a WHO briefing Tuesday to update member states on the outbreak. “We are extremely keen on understanding what WHO public health emergency funds are available for countries like ours ... We are short … $2 million, basically, to be able to have the kind of preparedness that would enable us to feel quite secure.”

    In South Asia, there have already been five cases documented in India, Nepal, and Sri Lanka.

    From the foundation’s funding, up to $20 million will go toward public health authorities in Africa and South Asia to strengthen emergency operations centers, develop effective surveillance systems, and improve capacity to isolate and treat confirmed cases. In Africa, this includes funds allocated to the African Field Epidemiology Network, the Africa Centers for Disease Control and Prevention and WHO Regional Office for Africa.

    Finally, up to $60 million of the Gates funding will be allocated toward accelerating the development and testing of vaccines, treatments, and diagnostics for 2019-nCoV. The funds will assist ongoing Chinese research partners, as well as support organizations like the Coalition for Epidemic Preparedness Innovations to identify research needs, incentivize product development by biotechnology and pharmaceutical companies, and ensure that products are safe and distributed widely.

    If the outbreak continues for several months or more, “safe and effective vaccines and therapeutics will be needed to help sustain long-term approaches to disease control and to prevent severe disease and deaths,” according to the Gates Foundation.

    Trials of the first coronavirus experimental drug from Gilead Sciences Inc. are expected to start next week.

    • Global Health
    • Funding
    • Gates Foundation
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Sara Jerving

      Sara Jervingsarajerving

      Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.

    Search for articles

    Related Jobs

    • Technical Advisor - Regulatory Consultancy
      U.S. Pharmacopeia
      Accra, Ghana | Ghana | West Africa
    • Medical Officer
      Aqaba, Jordan | Jordan | North Africa and Middle East
    • Senior Technical Advisor (Clinical Services)
      Port-au-Prince, Haiti | Haiti | Latin America and Caribbean
    • See more

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      How AI-powered citizen science can be a catalyst for the SDGs
    • 3
      Opinion: The missing piece in inclusive education
    • 4
      How to support climate-resilient aquaculture in the Pacific and beyond
    • 5
      Opinion: India’s bold leadership in turning the tide for TB

    Trending

    Financing for Development Conference

    The Trump Effect

    Newsletters

    Related Stories

    Funding InsightsHow the Gates Foundation spent $5.4 billion in 2024

    How the Gates Foundation spent $5.4 billion in 2024

    Devex NewswireDevex Newswire: Gates to give away fortune in historic philanthropic push

    Devex Newswire: Gates to give away fortune in historic philanthropic push

    Global healthOpinion: TB is back as top infectious killer. AI can change that

    Opinion: TB is back as top infectious killer. AI can change that

    Devex CheckUpDevex CheckUp: How Trump’s first 100 days fractured global health

    Devex CheckUp: How Trump’s first 100 days fractured global health

    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement